Multiple-ascending Dose, Safety, Tolerability, Pharmacokinetic, and Drug-drug Interaction Study with Lasmiditan
AHSAM 2020 - Oral session
Published on October 2, 2020 | NEW
In this medfyle
Expert commentary by by A. Laine Green, MSc, MD, FRCPC, FAHS
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AHSAM 2020 Virtual Annual Scientific Meeting and presented by:
Max Tsai, PhD
Eli Lilly and Company
Indianapolis, Indiana
The content is produced by Infomedica, the official reporting partner of ASHAM 2020 Virtual Annual Scientific Meeting. The summary text was drafted by Goldcrest Medical Writing, reviewed by Marco Vercellino, MD, an independent external expert, and approved by Jessica Ailani, MD, FAHS and Mark J. Burish, MD, PhD, the scientific editors of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
A. Laine Green, MSc, MD, FRCPC, FAHS
Assistant Professor and Staff Physician
Department of Neurology
Dartmouth Headache Center
Geisel School of Medicine at Dartmouth
About the Expert
A. Laine Green, MSc, MD, FRCPC, FAHS
Assistant Professor and Staff Physician
Department of Neurology
Dartmouth Headache Center
Geisel School of Medicine at Dartmouth
Dr. A. Laine Green is from Halifax Nova Scotia. His undergraduate degree was focused in organic chemistry. He then received a Master’s degree in synthetic (mechanistic) organic chemistry from Queen’s University. He completed his Medical School and Neurology residency training at Dalhousie University in Halifax. He completed his headache medicine fellowship with Dr. David Dodick at the Mayo Clinic in Arizona. His first year of fellowship was on the University of Arizona Campus in Tucson in the lab of Dr. Frank Porreca completing a preclinical project in medication overuse and cortical spreading depression. His second year of fellowship was the clinical based year with Dr. Dodick in Scottsdale. After fellowship Laine returned to Halifax where he was an Assistant Professor with the Division of Neurology at Dalhousie University for 5 years. In late 2019 he moved to Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth where he is an Assistant Professor in the Department of Neurology.
